Mind Medicine (MindMed) I... (MNMD)
5.46
-0.09 (-1.62%)
At close: Apr 04, 2025, 3:47 PM
Company Description
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology.
The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal.
It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder.
The company is headquartered in Vancouver, Canada.
Mind Medicine (MindMed) Inc.

Country | CA |
IPO Date | Nov 15, 2016 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 74 |
CEO | Robert Barrow |
Contact Details
Address: 1055 West Hastings Street Vancouver, BC CA | |
Website | https://www.mindmed.co |
Stock Details
Ticker Symbol | MNMD |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001813814 |
CUSIP Number | 60255C109 |
ISIN Number | CA60255C8850 |
Employer ID | 00-0000000 |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Robert Barrow | Chief Executive Officer & Director |
Mark R. Sullivan J.D. | Chief Legal Officer & Corporate Secretary |
Carrie F. Liao CPA, CGMA | Vice President & Chief Accounting Officer |
Dr. Daniel Rollings Karlin M.A., M.D. | Chief Medical Officer |
Dr. Gregg Pratt Ph.D. | Chief Regulatory & Quality Assurance Officer |
Dr. Scott M. Freeman M.D. | Co-Founder & Clinical Advisor |
Leonard Latchman | Co-Founder |
Matthew Wiley | Chief Commercial Officer |
Stephanie Fagan | Chief Corporate Affairs Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 26, 2025 | 4 | Filing |
Mar 26, 2025 | 4 | Filing |
Mar 26, 2025 | 4 | Filing |
Mar 26, 2025 | 4 | Filing |
Mar 18, 2025 | 4 | Filing |
Mar 18, 2025 | 3 | Filing |
Mar 13, 2025 | 4 | Filing |
Mar 13, 2025 | 4 | Filing |
Mar 13, 2025 | 4 | Filing |
Mar 13, 2025 | 4 | Filing |